Navigation Links
Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse

ents have taken Strattera worldwide. It has been studied in more than 6,000 patients in clinical trials, some for as long as three years.

It is not known precisely how Strattera reduces ADHD symptoms, but scientists believe it works by blocking or slowing reabsorption of norepinephrine, a chemical in the brain considered important in regulating attention, impulsivity and activity levels. This keeps more norepinephrine at work in the spaces between neurons in the brain. Improved efficiency in the norepinephrine system is associated with improvement in symptoms of ADHD.(4)

Important Safety Information

In some children and teens, Strattera increases the risk of suicidal thoughts. A combined analysis of 12 studies of Strattera showed that, in children and teens, this risk was 0.4 percent for those taking Strattera compared to none for those taking a sugar pill. A similar analysis in adults treated with Strattera did not reveal an increased risk of suicidal thoughts. Parents should call their doctor right away if their child has thoughts of suicide or sudden changes in mood or behavior, especially at the beginning of treatment or after a change in dose. Strattera should not be taken at the same time as, or within two weeks of taking, a monoamine oxidase inhibitor (MAOI) or by patients with narrow angle glaucoma.

Tell your doctor if you or a family member has a history of high or low blood pressure, increased heart rate, heart or blood vessel disease or structural heart defects. If you experience any cardiac symptoms, such as chest pain or fainting while taking Strattera, you should report them to your doctor right away. In rare cases, Strattera can cause liver problems. Call your doctor right away if you have itching, dark urine, yellow skin/eyes, upper right-side abdominal tenderness, or unexplained "flu-like" symptoms.

If your child develops new psychological symptoms, such as abnormal thoughts/behaviors and/or extreme elevated or irr
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:10/6/2008)...ldren, parents discussing clinical ...RNewswire-USNewswire/ -- From asthma and cancer,tr...ives and improves their,health and well-being. A n... (NIH), "Children and Clinical Studies", (http://w...ers parents and health,care providers an insider,s...
(Date:10/6/2008)...E Therapy is More Likely to Induce Steroid-Free ...rd Immunomodulator, Azathiopri...esented for the first time,from the Phase 3b Study...odulators and Biologic Therapy (SONIC) may provide...s with moderate to severe Crohn,s disease.,Accordi...
(Date:10/6/2008)...d for 9:00 AM ET Today -, SEATTLE, Oct. 6 /PRNews...NDN) announced today that it has completed the pla...double-blind, placebo-controlled IMPACT,(IMmunothe...nown as D9902B),clinical trial designed to assess ...ive cellular immunotherapy PROVENGE(R) (sipuleucel...
(Date:10/6/2008)...mpany,s Bioabsorbable Stent - Also,Slated for Pres...ire/ -- Data from multiple clinical trials of,the ...us Bio-engineered R,stent, will be presented next ...ics symposium, TCT 2008, in Washington, D.C., Rob...al Center in,Amsterdam will provide a Genous clini...
Breaking Medicine Technology:Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 2Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 3Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 2New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 5New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 6New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 7New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 8Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 2Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 3Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 4Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 3Possible link between baby swimming and breathing problems in children 2896 1Possible link between baby swimming and breathing problems in children 2896 2Academy of General Dentistry Releases Updated Employment Statistical Map 16841 1Academy of General Dentistry Releases Updated Employment Statistical Map 16841 2DelSite Signs Technology Evaluation Agreement With Global Pharmaceutical Company for GelSite 28R 29 Polymer 4609 1DelSite Signs Technology Evaluation Agreement With Global Pharmaceutical Company for GelSite 28R 29 Polymer 4609 2DelSite Signs Technology Evaluation Agreement With Global Pharmaceutical Company for GelSite 28R 29 Polymer 4609 3Leading HIV researchers to collaborate on vaccine development 16833 1Leading HIV researchers to collaborate on vaccine development 16833 2Leading HIV researchers to collaborate on vaccine development 16833 3
...E)--Apr 23, 2007 - Affitech AS, the,human antibody...ne,Pharmaceuticals, Inc. reported positive in vivo...body developed by Affitech, in a,pancreatic cancer...,Meeting of the American Association for Cancer Re...panies for selective blocking of,VEGF (vascular en...
...INESS WIRE)--Apr 23, 2007 - Aeolus,Pharmaceuticals...data by researchers at Loma Linda University Medic...oporphyrin antioxidants, AEOL,10113, may play an i...ced by ionizing radiation., Radiation therapy is u...therapy in the care and management of nearly all a...
Other Medicine Technology:Positive Results Using Affitech-Identified Human Antibody That,Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model,Reported by Peregrine 2Aeolus Pharmaceuticals' AEOL 10113 May Play an Important Role,Regulating the Oxidative Damage Induced by Ionizing Radiation 2Aeolus Pharmaceuticals' AEOL 10113 May Play an Important Role,Regulating the Oxidative Damage Induced by Ionizing Radiation 3
(Date:10/6/2008)...t. 6 /PRNewswire/ -- Developed in collaboration wi...ades, CA is introducing,Revolutionary Breast Surfa...c Surgery office of Dr. Steve Laverson this week i...he first of its kind, and is based on,breakthrough...with,innovative proprietary software. The XS-300(T...
(Date:10/6/2008)...ct. 6 /PRNewswire/ -- The organizers of Informex a...e on Global Sourcing for the,Pharmaceutical Indust...inceton Marriott in New Jersey USA., The conferen... the,Global Sourcing Council, and boasts an unpara...e likes of Johnson & Johnson, Bristol Myers Squibb...
(Date:10/6/2008)... LegalView recently posted detailed inform...he potentially serious side effects caused by the ... the drug,s potential side effects are the develop... for young adult and child patients. , ...- LegalView, the number one resource for everythin...
(Date:10/6/2008)... Hospital Ship Serving in West Africa Rece...Garden Valley, Texas October 6, 2008 -- www.seamob...l provider of communications services to remote lo...s to the FoxNews channel via satellite to Mercy Sh...ica Mercy. The Africa Mercy is the world,s larges...
Breaking Medicine News(10 mins):Health News:Plan Your Breasts in 3-D 2Health News:Global Sourcing Strategies for the Pharmaceutical Industry 10th - 11th November, Marriott Princeton, New Jersey USA 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 3Health News:Seamobile Provides Foxnews To Mercy Ships 2Health News:Seamobile Provides Foxnews To Mercy Ships 3
...their shoulder for rotator cuff pain relief or imp...ir regular activities for a few weeks, according t...s a molecular response in the tissue that is simil...y making it more vulnerable to damage during this ...
...hat young men who have never been traumatized are ...s recounting of child sexual abuse. The study – p...ogy of Women Quarterly – also finds that males wit...lieve that such incidents, if they happened at all...
...tudy they believe to be the first to evaluate the ... risks in the elderly.// Fine particle pollution...ss than 2.5 microns, about 1/30th the width of a h...aust, power plant emissions and burning of fossil ...
...trol (CDC)’s Morbidity and Mortality Weekly Report...isease than any other state,// while the U.S. Virg...sed on an analysis of 2005 data collected through ...System, a random phone survey of adults conducted ...
Other Medicine News:Health News:Steroids Cause the Same Tissue Changes as Tendon Injury 2Health News:Never-Betrayed Men Less Likely to Indulge in Child Sex Abuse 2Health News:Never-Betrayed Men Less Likely to Indulge in Child Sex Abuse 3Health News:Smog in Warm Weather may Contribute to Stroke Risks in Elderly: Study 2
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...
Medicine Products: